EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice

Maria Korom, Hong Wang, Kaelin M Bernier, Brian J Geiss, Lynda A Morrison

Viruses · 2023

DOI: 10.3390/v15071570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Maria Korom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 South Grand Blvd., St. Louis, MO 63104, USA. Hauptthemen laut MEDLINE: Herpesvirus 2, Human, Herpes Simplex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex virus 2 (HSV-2) causes most sexually transmitted genital ulcerative disease. No effective prophylactic vaccine is currently available. Replication-defective (ICP8-) HSV stimulates immune responses in animals without producing progeny virus, making it potentially useful as a safe form of a live vaccine against HSV. We previously demonstrated that mice generate a stronger response to ICP8- virus encoding B7-2 costimulation molecules than to the parental replication-defective virus. We have also demonstrated enhanced immunogenicity of an ICP8-, virion host shutoff (vhs)- virus which can no longer destabilize viral and host mRNAs. Here, we constructed a triple mutant, ICP8-vhs-B7-2+ strain, and compared it to both double mutant viruses. Immunization of mice with a single dose of ICP8-B7-2+ or ICP8-vhs-B7-2+ virus decreased challenge virus replication in the vaginal mucosa, genital disease, and mortality more effectively than immunization with the ICP8-vhs- virus. Immunization with ICP8-B7-2+ or ICP8-vhs-B7-2+ virus also effectively suppressed subsequent HSV-2 infection of the nervous system compared to immunization with the ICP8-vhs- virus. ICP8-B7-2+ and ICP8-vhs-B7-2+ strains induced more IFN gamma-producing CD8 T cells and memory CD8 T cells than did ICP8-vhs- virus, potentially explaining the enhanced protective effects. Thus, B7 costimulation molecules expressed from a replication-defective vaccine can enhance vaccine efficacy, even in an immunocompetent host.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 2, HumanHerpes SimplexFemaleMiceAnimalsB7 AntigensViral ProteinsVirus ReplicationVaccines, AttenuatedVirion

Stichwörter der Autor:innen

HSV-2T cellsantibodiescostimulationgenitalherpes simplex virusvaccine

Substanzen

B7 AntigensViral ProteinsVaccines, Attenuated

Autor:innen und Institutionen

  • Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 South Grand Blvd., St. Louis, MO 63104, USA.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Korom, M., Wang, H., Bernier, K. M., Geiss, B. J., & Morrison, L. A. (2023). ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice. Viruses. https://doi.org/10.3390/v15071570

Vancouver

Korom M, Wang H, Bernier KM, Geiss BJ, Morrison LA. ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice. Viruses. 2023. doi:10.3390/v15071570

BibTeX
@article{Korom2023,
  author = {Korom, Maria and Wang, Hong and Bernier, Kaelin M and Geiss, Brian J and Morrison, Lynda A},
  title = {ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15071570}
}
Kostenlos starten →